When validating these data, the authors demonstrated that these tumor-specific CD4+ T cells are able to kill tumor cells by a direct contact and granzyme-dependent mechanism, but with a delayed kinetic when compared to a more classical CTL. Here, CD4 is linked to neoplasm.